Tudor Investment Corp’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.7M | Sell |
632,552
-100,286
| -14% | -$8.02M | 0.07% | 197 |
|
|
2025
Q4 | $69.9M | Buy |
732,838
+72,652
| +11% | +$7.12M | 0.13% | 109 |
|
|
2025
Q3 | $64.5M | Buy |
660,186
+9,566
| +1% | +$991K | 0.11% | 130 |
|
|
2025
Q2 | $69.9M | Buy |
650,620
+394,489
| +154% | +$39.9M | 0.15% | 77 |
|
|
2025
Q1 | $25.8M | Buy |
+256,131
| New | +$25.8M | 0.09% | 146 |
|
|
2024
Q4 | – | Sell |
-329,804
| Closed | -$29M | – | 3035 |
|
|
2024
Q3 | $27.6M | Buy |
329,804
+315,270
| +2,169% | +$24.9M | 0.1% | 108 |
|
|
2024
Q2 | $1.12M | Sell |
14,534
-142,175
| -91% | -$10.4M | 0.01% | 1405 |
|
|
2024
Q1 | $10.7M | Sell |
156,709
-47,279
| -23% | -$3.04M | 0.07% | 329 |
|
|
2023
Q4 | $11.8M | Sell |
203,988
-104,697
| -34% | -$5.59M | 0.1% | 291 |
|
|
2023
Q3 | $16.3M | Buy |
308,685
+72,449
| +31% | +$3.8M | 0.16% | 92 |
|
|
2023
Q2 | $12.8M | Buy |
236,236
+17,634
| +8% | +$921K | 0.15% | 108 |
|
|
2023
Q1 | $10.9M | Buy |
+218,602
| New | +$10.3M | 0.17% | 125 |
|
|
2022
Q2 | – | Sell |
-28,173
| Closed | -$1.15M | – | 2115 |
|
|
2022
Q1 | $1.25M | Buy |
28,173
+11,417
| +68% | +$495K | 0.03% | 792 |
|
|
2021
Q4 | $712K | Buy |
16,756
+6,556
| +64% | +$275K | 0.01% | 1223 |
|
|
2021
Q3 | $443K | Buy |
+10,200
| New | +$451K | 0.01% | 1739 |
|
|
2021
Q2 | – | Sell |
-21,224
| Closed | -$820K | – | 1619 |
|
|
2021
Q1 | $820K | Buy |
21,224
+9,103
| +75% | +$345K | 0.02% | 931 |
|
|
2020
Q4 | $436K | Sell |
12,121
-69,180
| -85% | -$2.49M | 0.01% | 1002 |
|
|
2020
Q3 | $3.11M | Buy |
81,301
+48,401
| +147% | +$1.87M | 0.14% | 167 |
|
|
2020
Q2 | $1.16M | Sell |
32,900
-13,462
| -29% | -$485K | 0.06% | 429 |
|
|
2020
Q1 | $1.51M | Buy |
+46,362
| New | +$1.81M | 0.14% | 149 |
|
|
2019
Q2 | – | Sell |
-61,225
| Closed | -$2.35M | – | 1104 |
|
|
2019
Q1 | $2.35M | Buy |
+61,225
| New | +$2.34M | 0.1% | 236 |
|
|
2018
Q3 | – | Sell |
-30,623
| Closed | -$1M | – | 1088 |
|
|
2018
Q2 | $1M | Buy |
30,623
+3,936
| +15% | +$119K | 0.03% | 439 |
|
|
2018
Q1 | $729K | Sell |
26,687
-168,980
| -86% | -$4.59M | 0.02% | 440 |
|
|
2017
Q4 | $4.85M | Buy |
+195,667
| New | +$5.4M | 0.12% | 34 |
|
|
2016
Q4 | – | Sell |
-26,610
| Closed | -$633K | – | 1403 |
|
|
2016
Q3 | $633K | Sell |
26,610
-7,384
| -22% | -$176K | 0.01% | 614 |
|
|
2016
Q2 | $794K | Buy |
+33,994
| New | +$735K | 0.02% | 558 |
|
|
2015
Q3 | – | Sell |
-650,000
| Closed | -$11.5M | – | 1545 |
|
|
2015
Q2 | $11.5M | Buy |
650,000
+629,446
| +3,062% | +$11.2M | 0.34% | 53 |
|
|
2015
Q1 | $365K | Sell |
20,554
-141,947
| -87% | -$2.24M | 0.01% | 926 |
|
|
2014
Q4 | $2.15M | Buy |
162,501
+73,160
| +82% | +$935K | 0.07% | 139 |
|
|
2014
Q3 | $1.05M | Buy |
89,341
+62,301
| +230% | +$785K | 0.04% | 270 |
|
|
2014
Q2 | $345K | Buy |
27,040
+9,096
| +51% | +$118K | 0.01% | 763 |
|
|
2014
Q1 | $243K | Buy |
+17,944
| New | +$236K | 0.01% | 944 |
|
|
2013
Q4 | – | Sell |
-13,100
| Closed | -$154K | – | 1273 |
|
|
2013
Q3 | $154K | Buy |
+13,100
| New | +$142K | 0.01% | 757 |
|
Other funds holding BSX
VCM
VPM
Tudor Investment Corp's BSX Position: Q1 2026 in Review
Tudor Investment Corp reduced its Boston Scientific (BSX) stake by 14% in Q1 2026, selling an estimated $8.02M and leaving 632,552 shares worth $39.7M. The position accounts for 0.07% of the portfolio, ranked #197.
Tudor Investment Corp first reported a position in BSX in Q3 2013 and has held it in 33 quarters since. The position peaked at $69.9M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Tudor Investment Corp held 632,552 shares of Boston Scientific worth $39.7M as of Q1 2026.
- Tudor Investment Corp sold 100,286 Boston Scientific shares in Q1 2026, an estimated $8.02M.
- Boston Scientific made up 0.07% of Tudor Investment Corp's portfolio in Q1 2026, its #197 holding.
- Tudor Investment Corp first reported a position in Boston Scientific in Q3 2013 and has held it in 33 quarters since.
- Tudor Investment Corp's Boston Scientific position peaked at $69.9M in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.